KNW
BSX icon

Kesler Norman & Wride’s Boston Scientific BSX Stock Holding History

Kesler Norman & Wride’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,936
Closed -$623K – 274
2026
Q1 		$623K Sell
9,936
-3,079
-24% -$246K 0.11% 172
2025
Q4 		$1.24M Buy
13,015
+1,958
+18% +$192K 0.21% 106
2025
Q3 		$988K Sell
11,057
-446
-4% -$46.2K 0.19% 105
2025
Q2 		$1.24M Buy
11,503
+636
+6% +$64.4K 0.22% 97
2025
Q1 		$1.1M Sell
10,867
-190
-2% -$19.1K 0.21% 102
2024
Q4 		$988K Sell
11,057
-299
-3% -$26.3K 0.21% 100
2024
Q3 		$952K Buy
+11,356
New +$895K 0.19% 106

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Kesler Norman & Wride's BSX Position: Q2 2026 in Review

Kesler Norman & Wride sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 9,936 shares — an estimated $623K sold.

Kesler Norman & Wride first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $1.24M in Q4 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kesler Norman & Wride reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Kesler Norman & Wride sold 9,936 Boston Scientific shares in Q2 2026, an estimated $623K.
  • Kesler Norman & Wride first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Kesler Norman & Wride's Boston Scientific position peaked at $1.24M in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.